Your Partner For Timely, Accurate And High-Quality Preclinical Efficacy Studies

Aragen is a leading preclinical Contract Research Organization (CRO) that provides a full spectrum of high-quality preclinical efficacy services designed to accelerate your discovery efforts from initial research through to Investigational New Drug (IND) filing.

By partnering with us, you gain access to cutting-edge facilities and a team of experienced scientists with deep expertise in a wide range of therapeutic areas. Our capabilities include a robust portfolio of in vivo disease models, as well as advanced in vitro and ex vivo assays, enabling us to support diverse therapeutic candidates across multiple disease indications. Whether you're focused on oncology, immunology, or other complex diseases, Aragen is committed to delivering innovative and reliable preclinical solutions that drive your drug development forward efficiently and effectively.